EyePoint (EYPT) Cash & Equivalents (2010 - 2026)

EyePoint has reported Cash & Equivalents for 17 years, with the latest figure at $77.7 million in Q1 2026.

• Quarterly Cash & Equivalents fell 8.74% year-over-year to $77.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.7 million (down 8.74% YoY) and the FY2025 annual result came in at $101.8 million, up 2.12% from the prior year.
• Cash & Equivalents retreated to $77.7 million in Q1 2026 per EYPT's latest filing, from $101.8 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $281.3 million in Q4 2023 and troughed at $71.1 million in Q2 2025.
• A 5-year average of $115.7 million and a median of $95.6 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents soared 194.11% in 2023, then tumbled 68.58% in 2025.
• Over 5 years, Cash & Equivalents stood at $95.6 million in 2022, then soared by 194.11% to $281.3 million in 2023, then sank by 64.55% to $99.7 million in 2024, then climbed by 2.12% to $101.8 million in 2025, then fell by 23.68% to $77.7 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $77.7 million, $101.8 million, and $74.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.